Advertisement
Australia markets open in 7 hours 49 minutes
  • ALL ORDS

    8,076.70
    +11.20 (+0.14%)
     
  • AUD/USD

    0.6581
    -0.0020 (-0.30%)
     
  • ASX 200

    7,804.50
    +11.20 (+0.14%)
     
  • OIL

    79.04
    +0.66 (+0.84%)
     
  • GOLD

    2,327.70
    +3.50 (+0.15%)
     
  • Bitcoin AUD

    94,351.32
    -2,688.48 (-2.77%)
     
  • CMC Crypto 200

    1,324.37
    +29.70 (+2.29%)
     

Teladoc, Livongo Health Merger Valued At $18.5B

Teladoc Health Inc (NYSE: TDOC) shares are trading lower on Wednesday after the company announced a merger agreement with Livongo Health (NASDAQ: LVGO). The combination of the two businesses is expected to create a global leader in consumer-centered virtual care.

Teladoc will pay $11.33 per share along with exchanging each Livongo share with 0.592 shares of its own stock, representing a value of $18.5 billion based on the closing price of Teladoc Health shares as of Aug. 4.

Once the merger is complete, the existing Teladoc Health shareholders will own approximately 58% and existing Livongo shareholders will own approximately 42% of the combined company.

ADVERTISEMENT

The company will have expected 2020 pro forma revenue of approximately $1.3 billion, representing year over year pro forma growth of 85%. The combined company is expected to have pro forma Adjusted EBITDA of over $120 million for 2020.

Teladoc Health shares were trading down 2.17% at $244 in Wednesday’s pre-market session. The stock has a 52-week high of $253 and a 52-week low of $54.58.

Livongo Health shares were trading up 6.56% at $154.01. The stock has a 52-week high of $149.84 and a 52-week low of $15.12.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.